A citation-based method for searching scientific literature

Sreenivasa Rao Kondapally Seshasai, Stephen Kaptoge, Alexander Thompson, Emanuele Di Angelantonio, Pei Gao, Nadeem Sarwar, Peter H Whincup, Kenneth J Mukamal, Richard F Gillum, Ingar Holme, Inger Njølstad, Astrid Fletcher, Peter Nilsson, Sarah Lewington, Rory Collins, Vilmundur Gudnason, Simon G Thompson, Naveed Sattar, Elizabeth Selvin, Frank B Hu, John Danesh. N Engl J Med 2011
Times Cited: 1640







List of co-cited articles
299 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



High glucose promotes pancreatic cancer cell proliferation via the induction of EGF expression and transactivation of EGFR.
Liang Han, Qingyong Ma, Junhui Li, Han Liu, Wei Li, Guodong Ma, Qinhong Xu, Shuang Zhou, Erxi Wu. PLoS One 2011
86
2


Diabetes causes bone marrow autonomic neuropathy and impairs stem cell mobilization via dysregulated p66Shc and Sirt1.
Mattia Albiero, Nicol Poncina, Marc Tjwa, Stefano Ciciliot, Lisa Menegazzo, Giulio Ceolotto, Saula Vigili de Kreutzenberg, Rute Moura, Marco Giorgio, Piergiuseppe Pelicci,[...]. Diabetes 2014
100
2


Association of Time in Range, as Assessed by Continuous Glucose Monitoring, With Diabetic Retinopathy in Type 2 Diabetes.
Jingyi Lu, Xiaojing Ma, Jian Zhou, Lei Zhang, Yifei Mo, Lingwen Ying, Wei Lu, Wei Zhu, Yuqian Bao, Robert A Vigersky,[...]. Diabetes Care 2018
198
2


Association of glycemic variability and the presence and severity of coronary artery disease in patients with type 2 diabetes.
Gong Su, Shuhua Mi, Hong Tao, Zhao Li, Hongxia Yang, Hong Zheng, Yun Zhou, Changsheng Ma. Cardiovasc Diabetol 2011
169
2



Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.
David M Nathan, Patricia A Cleary, Jye-Yu C Backlund, Saul M Genuth, John M Lachin, Trevor J Orchard, Philip Raskin, Bernard Zinman. N Engl J Med 2005
2



Diabetes complications severity index and risk of mortality, hospitalization, and healthcare utilization.
Bessie Ann Young, Elizabeth Lin, Michael Von Korff, Greg Simon, Paul Ciechanowski, Evette J Ludman, Siobhan Everson-Stewart, Leslie Kinder, Malia Oliver, Edward J Boyko,[...]. Am J Manag Care 2008
405
2

Age at Diagnosis of Type 2 Diabetes Mellitus and Associations With Cardiovascular and Mortality Risks.
Naveed Sattar, Araz Rawshani, Stefan Franzén, Aidin Rawshani, Ann-Marie Svensson, Annika Rosengren, Darren K McGuire, Björn Eliasson, Soffia Gudbjörnsdottir. Circulation 2019
137
2

Effects of intensive glycaemic control on ischaemic heart disease: analysis of data from the randomised, controlled ACCORD trial.
Hertzel C Gerstein, Michael E Miller, Faramarz Ismail-Beigi, Joe Largay, Charlotte McDonald, Heather A Lochnan, Gillian L Booth. Lancet 2014
109
2

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Scott M Grundy, Neil J Stone, Alison L Bailey, Craig Beam, Kim K Birtcher, Roger S Blumenthal, Lynne T Braun, Sarah de Ferranti, Joseph Faiella-Tommasino, Daniel E Forman,[...]. Circulation 2019
2

Intensive glucose-lowering therapy reduces cardiovascular disease events in veterans affairs diabetes trial participants with lower calcified coronary atherosclerosis.
Peter D Reaven, Thomas E Moritz, Dawn C Schwenke, Robert J Anderson, Michael Criqui, Robert Detrano, Nicholas Emanuele, Moti Kayshap, Jennifer Marks, Sunder Mudaliar,[...]. Diabetes 2009
124
2

Follow-up of blood-pressure lowering and glucose control in type 2 diabetes.
Sophia Zoungas, John Chalmers, Bruce Neal, Laurent Billot, Qiang Li, Yoichiro Hirakawa, Hisatomi Arima, Helen Monaghan, Rohina Joshi, Stephen Colagiuri,[...]. N Engl J Med 2014
367
2

The Danish National Patient Registry: a review of content, data quality, and research potential.
Morten Schmidt, Sigrun Alba Johannesdottir Schmidt, Jakob Lynge Sandegaard, Vera Ehrenstein, Lars Pedersen, Henrik Toft Sørensen. Clin Epidemiol 2015
2


Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes.
Rodney A Hayward, Peter D Reaven, Wyndy L Wiitala, Gideon D Bahn, Domenic J Reda, Ling Ge, Madeline McCarren, William C Duckworth, Nicholas V Emanuele. N Engl J Med 2015
379
2

Intensive glucose control and macrovascular outcomes in type 2 diabetes.
F M Turnbull, C Abraira, R J Anderson, R P Byington, J P Chalmers, W C Duckworth, G W Evans, H C Gerstein, R R Holman, T E Moritz,[...]. Diabetologia 2009
783
2

Metformin: historical overview.
Clifford J Bailey. Diabetologia 2017
310
2


Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial.
Peter Gæde, Jens Oellgaard, Bendix Carstensen, Peter Rossing, Henrik Lund-Andersen, Hans-Henrik Parving, Oluf Pedersen. Diabetologia 2016
234
2

Long-term effects of metformin on metabolism and microvascular and macrovascular disease in patients with type 2 diabetes mellitus.
Adriaan Kooy, Jolien de Jager, Philippe Lehert, Daniël Bets, Michiel G Wulffelé, Ab J M Donker, Coen D A Stehouwer. Arch Intern Med 2009
264
2

A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF).
John J V McMurray, David L DeMets, Silvio E Inzucchi, Lars Køber, Mikhail N Kosiborod, Anna M Langkilde, Felipe A Martinez, Olof Bengtsson, Piotr Ponikowski, Marc S Sabatine,[...]. Eur J Heart Fail 2019
139
2

Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial.
Olga Vaccaro, Maria Masulli, Antonio Nicolucci, Enzo Bonora, Stefano Del Prato, Aldo P Maggioni, Angela A Rivellese, Sebastiano Squatrito, Carlo B Giorda, Giorgio Sesti,[...]. Lancet Diabetes Endocrinol 2017
135
2

Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis.
Connor A Emdin, Kazem Rahimi, Bruce Neal, Thomas Callender, Vlado Perkovic, Anushka Patel. JAMA 2015
436
2


Safety issues with glucagon-like peptide-1 receptor agonists (pancreatitis, pancreatic cancer and cholelithiasis): Data from randomized controlled trials.
Matteo Monami, Besmir Nreu, Alessia Scatena, Barbara Cresci, Francesco Andreozzi, Giorgio Sesti, Edoardo Mannucci. Diabetes Obes Metab 2017
86
2

Thiazolidinediones as antidiabetic agents: A critical review.
M J Nanjan, Manal Mohammed, B R Prashantha Kumar, M J N Chandrasekar. Bioorg Chem 2018
121
2

GLUcose COntrol Safety & Efficacy in type 2 DIabetes, a systematic review and NETwork meta-analysis.
Guillaume Grenet, Shams Ribault, Giao Bao Nguyen, Faustine Glais, Augustin Metge, Thomas Linet, Behrouz Kassai-Koupai, Catherine Cornu, Théodora Bejan-Angoulvant, Sylvie Erpeldinger,[...]. PLoS One 2019
7
28

Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)-a multicentre, double-blind, randomised, placebo-controlled trial.
Anders Jorsal, Caroline Kistorp, Pernille Holmager, Rasmus Stilling Tougaard, Roni Nielsen, Anja Hänselmann, Brian Nilsson, Jacob Eifer Møller, Jakob Hjort, Jon Rasmussen,[...]. Eur J Heart Fail 2017
215
2

Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial.
Michael Ej Lean, Wilma S Leslie, Alison C Barnes, Naomi Brosnahan, George Thom, Louise McCombie, Carl Peters, Sviatlana Zhyzhneuskaya, Ahmad Al-Mrabeh, Kieren G Hollingsworth,[...]. Lancet 2018
639
2

Evaluation of the effects of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and a preserved ejection fraction: rationale for and design of the EMPEROR-Preserved Trial.
Stefan D Anker, Javed Butler, Gerasimos S Filippatos, Waheed Jamal, Afshin Salsali, Janet Schnee, Karen Kimura, Cordula Zeller, Jyothis George, Martina Brueckmann,[...]. Eur J Heart Fail 2019
136
2

Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.
Kenneth B Margulies, Adrian F Hernandez, Margaret M Redfield, Michael M Givertz, Guilherme H Oliveira, Robert Cole, Douglas L Mann, David J Whellan, Michael S Kiernan, G Michael Felker,[...]. JAMA 2016
312
2

Impact of Diabetes Mellitus on Hospitalization for Heart Failure, Cardiovascular Events, and Death: Outcomes at 4 Years From the Reduction of Atherothrombosis for Continued Health (REACH) Registry.
Matthew A Cavender, Ph Gabriel Steg, Sidney C Smith, Kim Eagle, E Magnus Ohman, Shinya Goto, Julia Kuder, Kyungah Im, Peter W F Wilson, Deepak L Bhatt. Circulation 2015
269
2

Risk Related to Pre-Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection Fraction: Insights From Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial.
Søren L Kristensen, David Preiss, Pardeep S Jhund, Iain Squire, José Silva Cardoso, Bela Merkely, Felipe Martinez, Randall C Starling, Akshay S Desai, Martin P Lefkowitz,[...]. Circ Heart Fail 2016
182
2


A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease.
Majid Nikpay, Anuj Goel, Hong-Hee Won, Leanne M Hall, Christina Willenborg, Stavroula Kanoni, Danish Saleheen, Theodosios Kyriakou, Christopher P Nelson, Jemma C Hopewell,[...]. Nat Genet 2015
2

Mendelian randomization of blood lipids for coronary heart disease.
Michael V Holmes, Folkert W Asselbergs, Tom M Palmer, Fotios Drenos, Matthew B Lanktree, Christopher P Nelson, Caroline E Dale, Sandosh Padmanabhan, Chris Finan, Daniel I Swerdlow,[...]. Eur Heart J 2015
393
2

Genetic Association of Lipids and Lipid Drug Targets With Abdominal Aortic Aneurysm: A Meta-analysis.
Seamus C Harrison, Michael V Holmes, Stephen Burgess, Folkert W Asselbergs, Gregory T Jones, Annette F Baas, F N van 't Hof, Paul I W de Bakker, Jan D Blankensteijn, Janet T Powell,[...]. JAMA Cardiol 2018
46
4

Using multiple genetic variants as instrumental variables for modifiable risk factors.
Tom M Palmer, Debbie A Lawlor, Roger M Harbord, Nuala A Sheehan, Jon H Tobias, Nicholas J Timpson, George Davey Smith, Jonathan A C Sterne. Stat Methods Med Res 2012
285
2

Variants with large effects on blood lipids and the role of cholesterol and triglycerides in coronary disease.
Anna Helgadottir, Solveig Gretarsdottir, Gudmar Thorleifsson, Eirikur Hjartarson, Asgeir Sigurdsson, Audur Magnusdottir, Aslaug Jonasdottir, Helgi Kristjansson, Patrick Sulem, Asmundur Oddsson,[...]. Nat Genet 2016
156
2

Effects of combination lipid therapy in type 2 diabetes mellitus.
Henry N Ginsberg, Marshall B Elam, Laura C Lovato, John R Crouse, Lawrence A Leiter, Peter Linz, William T Friedewald, John B Buse, Hertzel C Gerstein, Jeffrey Probstfield,[...]. N Engl J Med 2010
2


Major lipids, apolipoproteins, and risk of vascular disease.
Emanuele Di Angelantonio, Nadeem Sarwar, Philip Perry, Stephen Kaptoge, Kausik K Ray, Alexander Thompson, Angela M Wood, Sarah Lewington, Naveed Sattar, Chris J Packard,[...]. JAMA 2009
2

Achievement of goals in U.S. diabetes care, 1999-2010.
Mohammed K Ali, Kai McKeever Bullard, Jinan B Saaddine, Catherine C Cowie, Giuseppina Imperatore, Edward W Gregg. N Engl J Med 2013
657
2


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.